DHR - Danaher Corporation

NYSE - NYSE Delayed Price. Currency in USD
141.02
-0.72 (-0.51%)
At close: 4:04PM EDT
Stock chart is not supported by your current browser
Previous Close141.74
Open141.39
Bid140.43 x 900
Ask141.04 x 1100
Day's Range140.02 - 142.75
52 Week Range94.59 - 145.50
Volume2,109,791
Avg. Volume2,214,138
Market Cap101.163B
Beta (3Y Monthly)0.84
PE Ratio (TTM)41.29
EPS (TTM)3.41
Earnings DateOct 16, 2019 - Oct 21, 2019
Forward Dividend & Yield0.68 (0.48%)
Ex-Dividend Date2019-06-27
1y Target Est154.92
Trade prices are not sourced from all markets
  • GE’s Recovery Remains on the Slow Track
    Bloomberg

    GE’s Recovery Remains on the Slow Track

    (Bloomberg Opinion) -- It’s been a busy week for General Electric Co. On Tuesday, the company announced it would sell another chunk of its stake in its Baker Hughes oil and gas venture, ultimately raising about $3 billion. Two day later, it said it would buy back up to $5 billion of bonds. This activity gave CEO Larry Culp something concrete to point to on Thursday when he took the podium at a Morgan Stanley conference to update analysts and investors on the industrial conglomerate’s turnaround progress. “We’re doing what we said we would do," Culp said. That means "tending to the balance sheet, making sure that we’re strengthening our overall financial position, and making sure that we’re in a position to run the businesses better."GE’s efforts to reduce its bloated debt load are a positive; that’s what it’s supposed to be doing. Culp’s ability and willingness to be proactive is undoubtedly an improvement over former CEO John Flannery’s long stretches of paralysis. But the timing of this flurry of deleveraging steps strikes me as slightly curious.Most companies wouldn’t go around buying back bonds when rates are so low; they would swap them out for new bonds at better terms. GE, however, has pledged not to add any new debt through 2021, and appears to be trying to signal its liquidity is such that it doesn’t need to. Yet Culp has also talked about running the company with a higher cash balance in order to reduce its reliance on commercial paper. And the $21.4 billion divestiture of GE’s biopharmaceutical business to Danaher Corp. – the linchpin in Culp’s debt reduction plan – hasn’t closed yet.Perhaps the Baker Hughes stake sale and the bond buyback were planned well in advance; perhaps GE is just being opportunistic and taking advantage of recent trading conditions. I can’t help but notice, though, that GE’s actions this week appeared to hit at the heart of criticisms made by Bernie Madoff whistle-blower Harry Markopolos last month in a lengthy, explosive report.Markopolos has an agreement with an undisclosed hedge fund that will give him a share of the profits from bets that GE shares will decline. GE has called his allegations “meritless.” His report claimed GE needed to immediately funnel $18.5 billion in cash into its troubled long-term care insurance business and accused the company of avoiding a writedown on its Baker Hughes stake. One way to read the debt buyback is that GE must not be too worried about a fresh cash shortfall at the insurance unit if it’s willing to plop down $5 billion to repurchase bonds on a voluntary basis. And GE’s stake sale this week will bring its holdings in Baker Hughes below 50%, which will prompt a charge that could be in the ballpark of $8 billion to $9 billion but also allow management to put one more inevitable writedown behind them.(1)There were a number of flaws in the Markopolos report, not least his liberal use of hyperbole, but it struck a nerve with investors who were already wary of more negative surprises at GE and the opaqueness of its underlying financials. Whether or not there’s any truth to his allegations, being on the hot seat like that appears to have shaken GE executives as well.What’s most telling is the one Markopolos criticism that GE hasn’t yet moved to address, and that is the lack of detailed transparency in its financial statements and the seeming differences in its aviation unit’s accounting relative to engine partner Safran SA. Culp missed an opportunity when he became CEO to move away from GE’s historical tendency to rely on a myriad of adjustments and a micromanaging of Wall Street expectations to bolster the appearance of the company’s results. This week’s actions and Culp’s presentation were in a way a reminder that of all of Markopolos’s claims, questionable as the others may be, that one has the potential to stick.Otherwise, the key takeaways from Culp’s Thursday presentation were that he expects the drop in interest rates to result in a “somewhere south” of $1.5 billion hit to its GAAP reserve assumptions for the long-term care insurance business, before accounting for any other adjustments as part of a third-quarter test. GE's projected pension benefit obligations, meanwhile, will also increase because of the drop in interest rates. Offsetting that is an improvement in returns, but GE is still looking at an impact in the $7 billion range, Culp said. Neither of those figures are disastrous, but serve as a reminder that it’s not just regular old debt that’s looming over GE. There are many other demands on its cash.Culp gave no update to GE’s expectation for roughly zero dollars in industrial free cash flow this year. Interestingly, he did allude to the idea that the company’s forecasts for 25 to 30 gigawatts of gas turbine demand this year may prove overly dire; still, I remain skeptical of GE’s ability to drive a huge surge in free cash flow at the power unit over the next few years. Other challenges at the company include persistent questions about the true underlying free cash flow of the aviation unit, the loss of cash-flow contributions from divested assets and the need to backstop its huge underfunded pension balance with more cash. Culp didn't rule out additional contributions to the pension over the next few years.Progress on the debt reduction front is good, but without a significant increase in free cash flow, it will be a while before GE can shift investors’ focus elsewhere. (1) GE said in July that deconsolidating Baker Hughes's results from its own would prompt a $7.4 billion writedown, based on the company's stock price at the time of $24.84. This week, it said every $1 change in Baker Hughes's stock price would increase or decrease that number by about $500 million. GE's share offering was priced at $21.50 and the stock was trading on Thursday for about $22.50.To contact the author of this story: Brooke Sutherland at bsutherland7@bloomberg.netTo contact the editor responsible for this story: Beth Williams at bewilliams@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Brooke Sutherland is a Bloomberg Opinion columnist covering deals and industrial companies. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.

  • Can General Electric Stock Move Past Immelt and Welch’s Sins?
    InvestorPlace

    Can General Electric Stock Move Past Immelt and Welch’s Sins?

    Larry Culp has been CEO of General Electric (NYSE:GE) for a year now and has made impressive strides against one of its biggest problems: the huge debts incurred by predecessor Jeff Immelt.Source: Jonathan Weiss / Shutterstock.com Long-term debt was down to $90 billion in June, and Culp has set plans to reduce it by about $30 billion more. These plans include the sale of GE Healthcare's biopharma unit to Danaher (NYSE:DHR) and a slow exit from Baker Hughes (NYSE:BHGE).But some of the biggest overhangs from the Immelt era, like GE Power, remain. So does one from the era of Jack Welch -- the reinsurance of long-term care policies highlighted by whistleblower Harry Markopolos.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Where's the Beef?What's worse is that the asset sales leave GE with few avenues to growth -- and these growth avenues are why investors buy stocks.GE reported a small loss of 1 cent per share for the June quarter. Its $28.8 billion of revenue was down over $1 billion from the previous June. Losing the biopharma unit and, eventually, taking Baker Hughes' revenue off the balance sheet, will reduce revenue further. * 10 Battered Tech Stocks to Buy Now Culp seems to be two-thirds of the way to a turnaround. He has stopped the bleeding and created a new, more transparent corporate culture. Growth is the next step.In December 2018, GE filed to spinoff its most promising growth avenue, GE Healthcare, through a mid-2019 IPO. But Culp hasn't talked about it in months. In February, Culp told CNBC that a 2019 IPO looks "unlikely." Many investors are waiting for an update.GE Healthcare accounts for one-sixth of the company's sales and nearly half its profit during good times. It seems to be the perfect platform on which Culp could work the magic he worked at Danaher. There he bought smaller healthcare companies, built their value and sold judiciously.GE Aviation, the other big profit driver, faces a $400 million per quarter hit to cash flow from the Boeing 737-MAX scandal. But the unit continues to perform, generating military contracts even as foreign nationals get hauled into court for stealing GE's trade secrets. Analysts are Pounding the Table for GE StockDespite a lack of growth catalysts, analysts keep pounding the table for GE stock. A Citi analyst has a "buy" rating on the stock. Others have dismissed Markopolos' charges, which I detailed in July, as overwrought.The argument is that with less debt and business prospects improving, the company is trading at barely two-thirds its sales.Any kind of profit would thus be a catalyst for the shares, initially as a defensive play but later, based on Culp's acquisition wizardry. This is especially true if, as some analysts now believe, it has enough reserves to handle the long-term care losses. The Bottom Line on General Electric StockIt's hard for me to buy the optimism yet, but there's an argument to be made.I think analysts still underestimate the damage Welch's long-term care time bomb could do. Given the high cost of nursing care, and the average age of those insured, this will remain a problem for years to come.But by the end of this year Culp may have cut GE's debt nearly in half through asset sales. If GE Power really is on a "positive trajectory," as one analyst recently claimed, it would take care of the last big downside risk.The question then becomes how Culp can create growth. The June quarter showed GE with over $71 billion in cash and short-term investments on its books. Some of that is committed to the remains of GE Capital, which Immelt used as a cash cow to build his power and energy conglomerate.But there may be enough there for Culp to shop for a healthcare acquisition. If he makes one, the stock will rise.Dana Blankenhorn is a financial and technology journalist. He is the author of the mystery thriller, The Reluctant Detective Finds Her Family, available at the Amazon Kindle store. Write him at danablankenhorn@gmail.com or follow him on Twitter at @danablankenhorn. As of this writing he owned no shares in companies mentioned in this article. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Battered Tech Stocks to Buy Now * 7 Strong-Buy Stocks Hedge Funds Are Buying Now * The 7 Best Penny Stocks to Buy The post Can General Electric Stock Move Past Immelt and Welch's Sins? appeared first on InvestorPlace.

  • Diversified Operations Industry Near-Term Prospects Bright
    Zacks

    Diversified Operations Industry Near-Term Prospects Bright

    Diversified Operations Industry Near-Term Prospects Bright

  • Honeywell (HON) Commissions Technology for Zhejiang Satellite
    Zacks

    Honeywell (HON) Commissions Technology for Zhejiang Satellite

    Zhejiang Satellite uses Honeywell's (HON) C3 Oleflex technology for the production of polymer-grade propylene at its facility in China.

  • General Electric to Get Roughly $3B From Stake Sale in BHGE
    Zacks

    General Electric to Get Roughly $3B From Stake Sale in BHGE

    General Electric's (GE) offering of Baker Hughes' shares to the public and Baker Hughes' decision to buy back own shares will likely raise roughly $3 billion. Funds will help in reducing debts.

  • 113-year-old Honeywell is transforming into a tech powerhouse
    Yahoo Finance

    113-year-old Honeywell is transforming into a tech powerhouse

    Honeywell is all in on tech across its product portfolio.

  • UTX or DHR: Which Is the Better Value Stock Right Now?
    Zacks

    UTX or DHR: Which Is the Better Value Stock Right Now?

    UTX vs. DHR: Which Stock Is the Better Value Option?

  • General Electric to Lose Controlling Stake in Baker Hughes
    Zacks

    General Electric to Lose Controlling Stake in Baker Hughes

    General Electric's (GE) offering of Baker Hughes' shares to the public and Baker Hughes' decision to buy back own shares comply with the restructuring plans announced in June 2018.

  • Danaher (DHR) Upgraded to Buy: Here's What You Should Know
    Zacks

    Danaher (DHR) Upgraded to Buy: Here's What You Should Know

    Danaher (DHR) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • General Electric Is a Buy Despite the Markopolos Report
    InvestorPlace

    General Electric Is a Buy Despite the Markopolos Report

    General Electric (NYSE:GE) finally looked to be out of the woods. GE stock bounced nicely earlier this year, and the company appeared to be turning things around. But a short seller has put GE stock back in the center of controversy once again. Harry Markopolos, famous for helping expose Bernie Madoff down, has sought out his next big target: General Electric.Source: testing / Shutterstock.com Markopolos dropped a 175-page report alleging all sorts of fraud and misrepresentations at GE. As a result, traders immediately dumped GE stock, though it quickly recovered much of its losses. Various analysts, including other short sellers, pointed out errors and hasty thinking in Markopolos' report. Still, many traders are operating under the thinking that where there's smoke there may be fire. GE stock has yet to reclaim the $10 per share mark following Markopolos' negative analysis of the firm. * 7 Best Stocks That Crushed It This Earnings Season Reasons For SkepticismAs InvestorPlace's James Brumley noted, there are many reasons to question the Markopolos report. For one, various folks ranging from bank analysts to fellow short sellers and even an ex-SEC chairman have suggested there were "suspicious" things about his work. Bronte Capital's fund manager John Hempton slammed the report as "utterly misleading" and "flat-out silly".InvestorPlace - Stock Market News, Stock Advice & Trading TipsWhile Markopolos deservedly earned his reputation with the Bernie Madoff investigation, it's far different going after a public company. It's one thing to expose a total ponzi scheme. But with GE, Markopolos is going after nuanced accounting things such as assumptions on long-term insurance policies where accountants can disagree.Look at something like Brighthouse Financial (NYSE:BHF) where the famed David Einhorn is long, short sellers are on the other side, and they are having a healthy debate around the value of its long-term insurance policies.Markopolos, by contrast, is running around screaming fraud while discussing complicated details.Why is Markopolos taking such a direct approach? He seems to be going for a financial reward. Markopolos is angling to earn money from an SEC whistleblower program along with working with a hedge fund that profits if the GE stock price goes down. These reasons would give Markopolos motivation to play up the incendiary language in his allegations. There Are Valid ConcernsWhile I'm skeptical about the Markopolos report and its intentions, there are some points the bears have latched onto that are worthy of further consideration. For example, GE has negative working capital -- and a lot of it. The figure pencils out around $10 to $20 billion depending on what all you count.What's this mean? General Electric owes more in short-term liabilities than it has in short-term assets. This can be a good thing. For example, think of a subscription business, where people pay you before you deliver a service to them. In the case of an industrial firm like GE, however, a large negative working capital position could mean the company is in weaker financial position than you'd think from a quick glance at its credit rating.In addition to the negative working capital point, analysts concede that Markopolos has some valid concerns on other things such as valuation marks on some divisions and how the value of long-term insurance contracts are calculated. But there's little evidence of anything close to outright fraud. It's Dangerous to Bet Against Larry CulpOne of the weirder things about calling GE a massive fraud is its management team. General Electric already cleaned the deck of its old team and brought in Larry Culp. For those unfamiliar, Culp was the longtime head of industrial powerhouse Danaher (NYSE:DHR). During Culp's tenure, Danaher stock appreciated roughly 500%. Culp is clearly a skilled leader, and there was no evidence of any wrongdoing in his previous highly-successful company.Once Markopolos leveled his charges against GE, Culp stepped in and bought GE stock aggressively. Culp said the allegations are baseless and defended the company with the strongest currency possible, his own money. In fact, Culp invested more in GE stock following the fraud claims than he invested in Danaher during his triumphant run at that firm. That's how much conviction Culp has that Markopolos is shooting blanks.Does a great leader guarantee that GE will succeed? Of course not. Sometimes even the greatest management teams face insurmountable challenges. And General Electric is admittedly in a pretty difficult situation. But in Culp, you have an honest and proven leader. GE Stock VerdictIf you're looking for a safe industrial stock to buy, don't pick GE. GE just announced its measly one cent quarterly dividend payment last week. That's a stark reminder of how far GE has fallen from when it was one of America's most respected blue chip holdings. If you want a safe reliable holding, something like Honeywell (NYSE:HON) or United Technologies (NYSE:UTX) is a better bet. * 10 Stocks to Sell in Market-Cursed September But if you are willing to speculate on a turnaround with a decent shot at success, GE is interesting. This Markopolos report could be a blessing in disguise, as it has aired some pointed questions about GE's accounting and offered investors a lot more transparency into the firm. As folks get more comfortable with Culp's vision for an improved General Electric, shares could rally nicely in coming quarters.At the time of this writing, Ian Bezek owned UTX and BHF stock. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post General Electric Is a Buy Despite the Markopolos Report appeared first on InvestorPlace.

  • PR Newswire

    Danaher Announces Quarterly Dividend

    WASHINGTON , Sept. 10, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, ...

  • Daniel Loeb's Top 5 Holdings as of the 2nd Quarter
    GuruFocus.com

    Daniel Loeb's Top 5 Holdings as of the 2nd Quarter

    Activist guru’s top holdings include Baxter and United Technologies Continue reading...

  • PR Newswire

    Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach

    WASHINGTON , Sept. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Water Quality Platform Investor and Analyst Meeting at Hach on September 17, 2019 beginning ...

  • If You Liked General Electric Stock Before, You Should Love It Now
    InvestorPlace

    If You Liked General Electric Stock Before, You Should Love It Now

    On Oct. 1, 2018, the General Electric (NYSE:GE) stock price closed at $11.62. In the 11-plus months since then, General Electric stock has struggled, falling by 25%.Source: Jonathan Weiss / Shutterstock.com Why is Oct. 1 meaningful? It's the day that Larry Culp, the celebrated former CEO of Danaher (NYSE:DHR), was named the new CEO of General Electric. Investors loved the move: the GE stock price closed 7% higher on the news. The hope was that Culp, who had presided over significant operating improvements at one industrial conglomerate, could work his magic at another.That hope seemed to fade quickly. Amid a plunging broad market, General Electric stock kept falling. In December, it briefly dipped below its financial crisis low of $6.66, touching a 25-year low in the process. A better broad market sparked an early 2019 rally, but accusations of accounting fraud last month sent shares tumbling.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Sell in Market-Cursed September For all the volatility and news, the irony is that not all that much seems to have changed in the last 11 months -- other than the GE stock price. Even the most bullish GE investor knew that Culp's turnaround efforts were going to take years to pay off. I've long been a GE bear, but even I have to admit: investors buying the turnaround last year should be absolutely loving General Electric stock below $9. A Busy Year for General Electric StockFrom one standpoint, GE stock looks very different now than it did last October. The company has aggressively sold assets to reduce its debt. Last month, GE Capital agreed to sell its aircraft leasing business for an estimated $4 billion to Apollo Global Management (NYSE:APO) and Athene Holding (NYSE:ATH). That follows a roughly $1 billion sale of energy investments to Apollo last year.In February, GE merged its transportation unit with Wabtec (NYSE:WAB), picking up cash in the process. It amended its agreements with Baker Hughes, a GE Company (NYSE:BHGE), and raised a few billion more in an offering of BHGE shares. Most notably, it agreed to sell its GE BioPharma business to Danaher for $21 billion.There have been concerns about the exposure of GE Aviation to the 737 MAX debacle at Boeing (NYSE:BA). As noted above, the company was accused of accounting fraud in GE Capital's long-term healthcare business. GE Power showed signs of life in the second quarter.Simply put, there has been a ton of news when it comes to General Electric stock. And yet, from another perspective, not all that much has changed. Has the Story Changed?As far as the asset sales and spin-offs go, it's not entirely clear that they created -- or destroyed -- all that much value for GE stock. General Electric obviously is giving up profit streams in exchange for near-term cash. That improves the balance sheet -- a key reason why General Electric bonds have outperformed General Electric stock - but doesn't necessarily change the total value of General Electric's business.Even the big sale to Danaher, which seemed like a logical step, wound up ending hopes for a spinoff of GE Healthcare. GE sold its Baker Hughes shares at $23; BHGE closed Friday at $23.53. The Alstom acquisition remains a weight around the neck of GE Power. The 737 MAX issues at Boeing could be good news - more spare parts sales for existing aircraft - while engine issues with that manufacturer's 777X add to the sense that Aviation truly is the hinge when it comes to GE stock.Even at GE Capital, it's not as if investors didn't know there were problems in the long-term healthcare business. The company took a $6 billion charge in January 2018 related to the unit. An analyst argued last October that reserves still weren't high enough.From a broad standpoint, this is a company still in year one of a multi-year turnaround. Power still needs to get fixed. Healthcare is a good business. Aviation likely is as well. And GE Capital seems like a black hole.None of that is news. Despite $30 billion-plus in asset sale proceeds, none of that really has changed. GE bulls bet a year ago that Culp could turn around a business that still had real value. Bears -- myself included -- argued that there simply wasn't that much underlying value anyhow. That argument still holds, and it still hasn't been resolved. A Lower GE Stock Price MattersIndeed, I argued in May of 2018 that, even in a breakup, GE stock probably was worth at most between $11 and $13. And so the price offered in October hardly seemed all that attractive.Truthfully, $9 doesn't quite, either. A ~30% decline in BHGE shares takes at least $1 off those targets. The news surrounding GE Capital, even putting the recent report aside, seems modestly worse than it appeared at that point. * 7 of the Worst IPO Stocks in 2019 But other investors can, and have, come to a different conclusion. There were investors happy to pay almost $12 for General Electric stock less than a year ago. Those who bought the stock then should see the trading of the past eleven months as an opportunity, not a problem.GE stock remains a bet that Culp can get value out of the "good" businesses -- Healthcare and Aviation -- while minimizing the damage from Capital and Power. That bet hasn't been proven right yet, of course. But bulls can at least point the fact that it hasn't been proven wrong yet, either.As of this writing, Vince Martin did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 3 Artificial Intelligence Stocks to Buy * 7 Industrial Stocks to Buy for a Strong U.S. Economy * 3 Beaten-Down Bank Stocks to Buy and Hold for the Long Term The post If You Liked General Electric Stock Before, You Should Love It Now appeared first on InvestorPlace.

  • Is General Electric Stock Worth the Risk?
    InvestorPlace

    Is General Electric Stock Worth the Risk?

    General Electric (NYSE:GE) is one of America's oldest and best-known companies. As one of the original 12 members of the Dow Jones Industrial Average, General Electric stock was viewed by generations of Americans as a solid investment.However, the company has grown in complexity and is involved in a lot more than power and lighting these days, as investors know all too well. A whistleblower report alleging accounting fraud at GE in general, and in particular in the company's long-term care insurance unit, resulted in an 11% one-day crash by General Electric stock on Aug. 15. Source: Pavel Kapysh / Shutterstock.com There's been a tentative recovery in the GE stock price since it tanked on Aug. 15. General Electric stock is now up 20% in 2019, although it has given up the gains it made from January through August. With its new CEO approaching his first-year anniversary at the helm and after reporting better than expected Q2 earnings and guidance, is GE worth a look? Or does the current risks facing General Electric stock outweigh any potential gains? InvestorPlace - Stock Market News, Stock Advice & Trading Tips The Next Enron?Up until mid-August, GE was having a pretty good year; or, at least General Electric stock was doing well for investors. There were a few rocky periods, but by the end of July, GE stock price was sitting at $10.45 which represented a 38% gain on the year. However, just two weeks later, a shocking report torpedoed GE stock and raised serious questions about the company's future. * 7 Industrial Stocks to Buy for a Strong U.S. Economy On August 15, Madoff whistleblower Harry Markopolos, an accountant, released a 175-page report detailing alleged fraud at General Electric, going back decades. Markopolos claims that after more than a year of investigation, he uncovered $38 billion of accounting fraud at GE, including an alleged cover-up of massive losses in the company's long-term care insurance unit (GE had to boost that unit's reserve funds by $15 billion last year). Markopolos launched the GEFraud website to host the report and provide details on what he describes as "a bigger fraud than Enron."Markopolos pulled no punches when he told CNBC: "It's going to make this company probably file for bankruptcy"The market's reaction to the blockbuster report was swift. General Electric stock plunged 11% in its biggest one-day drop in a decade. Can Larry Culp Turn Around General Electric Stock?Larry Culp took the reins as GE's 12th CEO last October. There were high hopes for his tenure. Holding a Harvard MBA, Culp became the first outsider to run GE. He made a name for himself by boosting Danaher's (NYSE:DHR) top line from $4 billion to $20 billion during his 14 years as its CEO. Despite initial hopes that he could "fix" GE, investors' confidence in its turnaround has waned. General Electric stock dropped from $12.69 in the days after his run at CEO began to as low as $6.71 in December, before staging a partial recovery over the summer. Less than a year into his tenure, the jury is out on whether Culp will be able to return General Electric to its former glory. However, he has received praise for his reaction to the whistleblower report. Culp went on the attack, calling the report "market manipulation" that contains false statements. In addition, Culp put his money where his mouth is, buying nearly $2 million worth of GE stock immediately after the report went public. The Bottom Line on GE StockShould investors buy General Electric stock? Even after crawling out of the hole created by the Markopolos report, the current GE stock price remains well below its 2019 highs. The shares are off nearly 70% from their fall 2016 levels. Morgan Stanley recently put a $10 price target on GE stock, but remains cautious. InvestorPlace contributor Tom Taulli recommends that investors hold off on adding General Electric to their portfolios, noting the company's high debt load, the risk of slowing global economic growth and the challenge that CEO Larry Culp faces in turning around a company as big and complex as GE. In other words, at this point, the risks facing GE stock probably outweigh its potential rewards.As of this writing, Brad Moon did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Is General Electric Stock Worth the Risk? appeared first on InvestorPlace.

  • Reuters

    Thermo Fisher, Danaher among firms competing for KKR's LGC Group - Bloomberg

    Medical device makers Thermo Fisher Scientific Inc and Danaher Corp have expressed interest in KKR & Co's potential sale of its scientific measurement and testing company LGC Group, Bloomberg reported on Friday. The sale of LGC could get the private equity firm more than $2 billion, including debt, the report said, citing people familiar with the matter. Blackstone Group Inc, Carlyle Group LP, CVC Capital Partners and EQT Partners are also weighing offers for the business, according to the report, which added that the talks are at an early stage.

  • Thermo Fisher, Danaher Among Firms Eyeing KKR's LGC
    Bloomberg

    Thermo Fisher, Danaher Among Firms Eyeing KKR's LGC

    (Bloomberg) -- KKR & Co.’s potential sale of British scientific measurement and testing company LGC Group has attracted initial interest from suitors including Thermo Fisher Scientific Inc. and Danaher Corp., people familiar with the matter said.Blackstone Group Inc., Carlyle Group LP, CVC Capital Partners and EQT Partners are also weighing offers for the business, the people said, asking not to be identified because the deliberations are private. LGC could fetch more than $2 billion including debt in a sale, the people said.Suitors expect KKR to send out a so-called information memorandum later this month with preliminary information on the business, the people said.LGC helps test whether foods contain allergens or if racing greyhounds have been doping. The company generates annual earnings before interest, taxes, depreciation and amortization of about $150 million after factoring in its recent acquisitions, the people said.Deliberations are at an early stage, and there’s no certainty the suitors will proceed with firm bids, the people said. Representatives for Blackstone, CVC, EQT, KKR and Thermo Fisher declined to comment. A spokeswoman for Carlyle said she couldn’t immediately comment, while representatives for Danaher didn’t respond to requests for comment.KKR is working with advisers as it looks for ways to exit its holding in the business, which it bought in 2016, people familiar with the process said previously. The company has made a number of acquisitions since the buyout firm’s investment.In August, LGC bought a majority stake in Toronto Research Chemicals, a firm that makes chemicals used in reference standards and research. That deal followed its September 2018 acquisition of reagents maker Berry & Associates.LGC traces its origins to 1842 to a body created in London to regulate tobacco adulteration. It still provides independent chemical and bioanalytical measurements. Previously known as Laboratory of the Government Chemist, the firm was privatized in 1996.\--With assistance from Kristen V. Brown.To contact the reporters on this story: Sarah Syed in London at ssyed35@bloomberg.net;Dinesh Nair in London at dnair5@bloomberg.netTo contact the editors responsible for this story: Dinesh Nair at dnair5@bloomberg.net, Amy Thomson, Ben ScentFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.

  • Moody's

    Danaher Corporation -- Moody's assigns Baa1 senior unsecured rating to Danaher's new notes

    Moody's Investors Service ("Moody's") assigned a Baa1 rating to the new senior unsecured notes of DH Europe Finance II S.a r.l., an indirect and wholly owned subsidiary of Danaher Corporation ("Danaher"). Danaher will fully and unconditionally guarantee the new notes. Proceeds from the new European notes will be used in conjunction with additional debt, equity and existing cash on hand to fund the roughly $21 billion acquisition of GE Biopharma.

  • Danaher initiates stock sale to help finance $21B GE Biopharma acquisition
    American City Business Journals

    Danaher initiates stock sale to help finance $21B GE Biopharma acquisition

    D.C.-based Danaher Corp. (NYSE: DHR) is initiating a stock sale to finance its $21 billion acquisition of General Electric Co.’s biopharma business. The company said Tuesday it expects net proceeds of its sale — being made through Luxembourg subsidiary DH Europe Finance II SARL— to reach 6.197 billion euros, or roughly $6.843 billion, after deducting underwriting discounts and offering expenses. Danaher said it may invest the net proceeds in short-term bank deposits or invest them in interest-bearing securities.

  • Benzinga

    Citi: General Electric's Recovery 'Could Be More Significant' Than Investors Realize

    General Electric Company (NYSE: GE) shares traded higher by another 4.5% on Wednesday after yet another analyst had good things to say about the stock. After meeting with General Electric CEO Larry Culp, Kaplowitz said he is more optimistic about GE’s turnaround efforts. While GE is far from out of the woods just yet, Kaplowitz said the company’s near-term goals of +/- $1 billion in free cash flow and EPS of between 55 cents and 65 cents in 2019 is achievable.

  • Danaher's Senior Notes Offerings to Fund BioPharma Buyout
    Zacks

    Danaher's Senior Notes Offerings to Fund BioPharma Buyout

    Danaher's (DHR) subsidiary prices euro 6.25 billion worth of senior notes offerings. The net proceeds will be used for paying for the pending acquisition of General Electric's BioPharma business.

  • PR Newswire

    Envista Announces Launch of IPO Roadshow

    BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase up to 4,015,200 additional shares of common stock at the IPO price, less underwriting discounts and commissions.  The IPO price is currently expected to be between $21.00 and $24.00 per share.

  • PR Newswire

    Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

    WASHINGTON , Sept. 3, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International ...

  • Moody's

    DH Europe Finance II S.a.r.l. -- Moody's assigns Baa1 senior unsecured rating to Danaher's new notes

    Moody's Investors Service ("Moody's") assigned a Baa1 rating to the new senior unsecured notes of DH Europe Finance II S.a r.l., an indirect and wholly owned subsidiary of Danaher Corporation ("Danaher"). Danaher will fully and unconditionally guarantee the new notes. Proceeds from the new European notes will be used in conjunction with additional debt, equity and existing cash on hand to fund the roughly $21 billion acquisition of GE Biopharma.

  • Simple Market Timing Strategies That Work - September 02, 2019
    Zacks

    Simple Market Timing Strategies That Work - September 02, 2019

    Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?